Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
Saved in:
| Title: | Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study. |
|---|---|
| Authors: | Pearce I; St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom. Electronic address: ian.pearce@rlbuht.nhs.uk., Banerjee S; University Hospital of Wales, Cardiff, United Kingdom., Burton BJ; James Paget University Hospital, Great Yarmouth, United Kingdom., Chakravarthy U; Royal Victoria Hospital, Belfast, United Kingdom., Downey L; Hull and East Yorkshire Eye Hospital, Hull, United Kingdom., Gale RP; York Teaching Hospital, York, United Kingdom., Gibson J; Birmingham Heartlands Hospital, Birmingham, United Kingdom., Pagliarini S; University Hospitals Coventry & Warwickshire, Hospital of St Cross, Rugby, United Kingdom., Patel J; Essex County Hospital, Colchester, United Kingdom., Sivaprasad S; Kings College Hospital, London, United Kingdom., Andrews C; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom., Brittain C; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Warburton J; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom. |
| Corporate Authors: | RELIGHT Study Group |
| Source: | Ophthalmology [Ophthalmology] 2015 Sep; Vol. 122 (9), pp. 1811-9. Date of Electronic Publication: 2015 Jul 03. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1549-4713 |
|---|---|
| DOI: | 10.1016/j.ophtha.2015.05.038 |
